Risperdal Consta for Bipolar Disorder

This study has been completed.
Sponsor:
Collaborator:
Janssen Pharmaceuticals
Information provided by (Responsible Party):
K.N. Roy Chengappa, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00177164
First received: September 12, 2005
Last updated: January 11, 2013
Last verified: January 2013